Viyash Scientific share news, announcements and annual reports
NSE: VIYASHBSE: 512529Pharmaceuticals & BiotechnologySmall Cap
Viyash Scientific Limited · Formerly Sequent Scientific · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1990 on BSE, Mar 2016 on NSE
Last close ₹218.39down ₹6.16 (2.74%)BSE ₹218.50
Share price at the NSE close on 30 Oct 2026. Previous close ₹224.55.
30 Oct: open ₹224.59, high ₹225.84, low ₹217.35
52-week range of traded prices to 30 Oct 2026
₹178.13Low, 23 Mar 2026₹298.00High, 6 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,645 Cr598th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,13,10753.2% delivered
Viyash Scientific share news and announcements
593 announcements, routine notices left out, newest first. Page 6 of 12.
Nov 2022
Sep 2022
21 Sep · Meeting
Aug 2022
25 Aug · Legal
Exchange has sought clarification from Sequent Scientific Limited with respect to announcement dated 09-May-2022 informing about Fire incident in wholly owned subsidiary's Unit at Ramky Pharma City SEZ JNPC, Visakhapatnam.On the basis of aforesaid announcement, the Company is required to provide/clarify the following:Disruption of operations due to natural calamity, force majeure or events such as strikes, lockouts etc (At the time of occurrence) 1. Expected quantum of loss/damage caused; 2. Whether loss/damage covered by insurance or not including amount; 3. Estimated impact on the production/operations in case of strikes/lock outs; Disruption of operations due to natural calamity, force majeure or events such as strikes, lockouts etc (Regularly, till complete normalcy is restored) 1. Insurance amount claimed and realized by the listed entity for the loss/damage; 2. The actual amount of damage caused due to the natural calamity or other force majeure events; 3. Details of steps taken to restore normalcy and the impact of the natural calamity/other force majeure events on production or service, financials of the entity The response of the company is awaited.
Jul 2022
Jun 2022
9 Jun · Related Party Transaction
May 2022
25 May · Results
24 May · Legal
The exchange asked on 23 May 2022
18 May · Analysts
Apr 2022
11 Apr · Disclosure
11 Apr · Meeting
Mar 2022
Feb 2022
11 Feb · Results
11 Feb · Board meeting
4 Feb · Analysts
4 Feb · Board meeting
Jan 2022
Dec 2021
10 Dec · Legal
The exchange asked on 9 Dec 2021
Nov 2021
27 Nov · Related Party Transactions
16 Nov · Analysts
1 Nov · Results
1 Nov · Board meeting
Oct 2021
25 Oct · Analysts
25 Oct · Board meeting
Sep 2021
23 Sep · Meeting